Kwality Pharmaceuticals Limited provided earnings guidance for the fiscal year 2023. For the period, the company expects revenue to be in the range of INR 3,500 million and INR 4,000 million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
507 INR | +1.36% | +13.03% | +26.81% |
1st Jan change | Capi. | |
---|---|---|
+26.81% | 63.08M | |
+25.83% | 661B | |
+27.00% | 566B | |
-6.76% | 352B | |
+20.34% | 332B | |
+3.00% | 283B | |
+13.09% | 231B | |
+5.46% | 200B | |
-9.61% | 195B | |
-6.26% | 145B |
- Stock Market
- Equities
- KPL6 Stock
- News Kwality Pharmaceuticals Limited
- Kwality Pharmaceuticals Limited Provides Earnings Guidance for the Fiscal Year 2023